Christina Kay
2017
In 2017, Christina Kay earned a total compensation of $180.8K as Co, Chief Executive Officer Executive Vice President at Integrated Biopharma.
Compensation breakdown
| Option Awards | $1,683 |
|---|---|
| Salary | $172,963 |
| Other | $6,203 |
| Total | $180,849 |
Kay received $173K in salary, accounting for 96% of the total pay in 2017.
Kay also received $1.7K in option awards and $6.2K in other compensation.
Rankings
In 2017, Christina Kay's compensation ranked 14,141st out of 14,666 executives tracked by ExecPay. In other words, Kay earned more than 3.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 14,141 out of 14,666 | 4th |
Division Manufacturing | 5,552 out of 5,772 | 4th |
Major group Chemicals And Allied Products | 1,993 out of 2,075 | 4th |
Industry group Drugs | 1,660 out of 1,731 | 4th |
Industry Pharmaceutical Preparations | 1,273 out of 1,333 | 5th |
Source: SEC filing on October 28, 2019.
Kay's colleagues
We found three more compensation records of executives who worked with Christina Kay at Integrated Biopharma in 2017.
News
Integrated Biopharma CFO Dina Masi's 2024 pay rises 8% to $357K
October 28, 2024
Integrated Biopharma CFO Dina Masi's 2023 pay rises 10% to $330K
October 27, 2023
Integrated Biopharma CFO Dina Masi's 2022 pay rises 12% to $300K
October 27, 2022
Integrated Biopharma CFO Dina Masi's 2021 pay rises 6% to $268K
October 27, 2021
Integrated Biopharma CFO Dina Masi's 2019 pay rises 4% to $251K
October 28, 2019